Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C G Swahn

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Nuclear Medicine and Biology|November 1, 1995
The metabolite pattern of [123I]beta-CIT determined with a gradient HPLC methodK A Bergström, C Halldin, J T Kuikka, et al.
Nuclear Medicine and Biology|April 1, 1993
[11C] beta-CIT, a cocaine analogue. Preparation, autoradiography and preliminary PET investigationsL Müller, C Halldin, L Farde, et al.
Synapse (New York, N.Y.)|May 20, 2000
Dopamine D(2) receptor quantification in extrastriatal brain regions using [(123)I]epidepride with bolus/infusionL H Pinborg, C Videbaek, G M Knudsen, et al.
Acta Radiologica. Supplementum|January 1, 1991
Cerebral glucose utilization measured by positron emission tomography. [1-11C]-D-glucose compared with [2-18F]-2-fluoro-2-deoxy-D-glucoseG Blomqvist, S Stone-Elander, C Halldin, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|July 1, 1990
Positron emission tomographic measurements of cerebral glucose utilization using [1-11C]D-glucoseG Blomqvist, S Stone-Elander, C Halldin, et al.
Nuclear Medicine and Biology|October 1, 1995
[O-methyl-11C]beta-CIT-FP, a potential radioligand for quantitation of the dopamine transporter: preparation, autoradiography, metabolite studies, and positron emission tomography examinationsC Lundkvist, C Halldin, C G Swahn, et al.
European Journal of Nuclear Medicine|February 1, 1994
Preparation of a potential positron emission tomographic radioligand for the dopamine transporterL Müller, C Halldin, C Foged, et al.
European Journal of Nuclear Medicine|November 5, 1997
Bromine-76 and carbon-11 labelled NNC 13-8199, metabolically stable benzodiazepine receptor agonists as radioligands for positron emission tomographyC Foged, C Halldin, C Loc'h, et al.
Nuclear Medicine and Biology|April 11, 2001
New halogenated [11C]WAY analogues, [11C]6FPWAY and [11C]6BPWAY--radiosynthesis and assessment as radioligands for the study of brain 5-HT1A receptors in living monkeyJ Sandell, C Halldin, V W Pike, et al.
Nuclear Medicine and Biology|April 1, 1996
Development of 123I-labelled NNC 13-8241 as a radioligand for SPECT visualization of benzodiazepine receptor bindingC Foged, C Halldin, J Hiltunen, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Nuclear Medicine and Biology|November 1, 1995
The metabolite pattern of [123I]beta-CIT determined with a gradient HPLC methodK A Bergström, C Halldin, J T Kuikka, et al.
Nuclear Medicine and Biology|April 1, 1993
[11C] beta-CIT, a cocaine analogue. Preparation, autoradiography and preliminary PET investigationsL Müller, C Halldin, L Farde, et al.
Synapse (New York, N.Y.)|May 20, 2000
Dopamine D(2) receptor quantification in extrastriatal brain regions using [(123)I]epidepride with bolus/infusionL H Pinborg, C Videbaek, G M Knudsen, et al.
Acta Radiologica. Supplementum|January 1, 1991
Cerebral glucose utilization measured by positron emission tomography. [1-11C]-D-glucose compared with [2-18F]-2-fluoro-2-deoxy-D-glucoseG Blomqvist, S Stone-Elander, C Halldin, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|July 1, 1990
Positron emission tomographic measurements of cerebral glucose utilization using [1-11C]D-glucoseG Blomqvist, S Stone-Elander, C Halldin, et al.
Nuclear Medicine and Biology|October 1, 1995
[O-methyl-11C]beta-CIT-FP, a potential radioligand for quantitation of the dopamine transporter: preparation, autoradiography, metabolite studies, and positron emission tomography examinationsC Lundkvist, C Halldin, C G Swahn, et al.
European Journal of Nuclear Medicine|February 1, 1994
Preparation of a potential positron emission tomographic radioligand for the dopamine transporterL Müller, C Halldin, C Foged, et al.
European Journal of Nuclear Medicine|November 5, 1997
Bromine-76 and carbon-11 labelled NNC 13-8199, metabolically stable benzodiazepine receptor agonists as radioligands for positron emission tomographyC Foged, C Halldin, C Loc'h, et al.
Nuclear Medicine and Biology|April 11, 2001
New halogenated [11C]WAY analogues, [11C]6FPWAY and [11C]6BPWAY--radiosynthesis and assessment as radioligands for the study of brain 5-HT1A receptors in living monkeyJ Sandell, C Halldin, V W Pike, et al.
Nuclear Medicine and Biology|April 1, 1996
Development of 123I-labelled NNC 13-8241 as a radioligand for SPECT visualization of benzodiazepine receptor bindingC Foged, C Halldin, J Hiltunen, et al.
Pageof 8